Shine-On BioMedical Co.,Ltd. (6926.TWO)

TWD 66.0

(-1.35%)

Market Cap (In TWD)

3.28 Billion

Revenue (In TWD)

9.52 Million

Net Income (In TWD)

-37.16 Million

Avg. Volume

11.43 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
61.1-69.6
PE
-
EPS
-
Beta Value
0.0
ISIN
TW0006926009
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Hongzhe Jiang
Employee Count
-
Website
https://www.shineon-bio.com
Ipo Date
2022-11-25
Details
Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. The company was founded in 2021 and is based in Taichung, Taiwan.